The FA community learned this month that the FDA pivoted and asked Reata to request a Pre-NDA meeting for Omaveloxolone. This action was a direct result of your advocacy! Sharing your story was influential in educating and engaging those who received FARA’s petition. Your voice was heard! There is now another opportunity for action.
On May 25, 2021, US Representatives Jeff Fortenberry (NE-01) and Mike Quigley (IL-05), with Senators Chris Coons (D-DE) and Lisa Murkowski (RAK) re-introduced the bipartisan, bicameral Accelerating Access to Critical Therapies (ACT) for ALS (H.R. 3537/S. 1813). This legislation has 99 original co-sponsors in the House.
FARA Advocacy Newsletter - May 2021
- Category: News & Press Releases
More...Read the Full Advocacy Newsletter